Acute infections in children are accompanied by oxidative modification of LDL and decrease of HDL cholesterol, and are followed by thickening of carotid intima–media

Petru Liubaa,*, Jerker Perssonb, Jukka Luomac, Seppo Ylä-Herttualac and Erkki Pesonena

a Division of Pediatric Cardiology, Department of Paediatrics, Lund University Hospital, 221 85 Lund, Sweden
b Department of Cardiology, Malmö University Hospital, Malmö, Sweden
c A.I. Virtanen Institute of Molecular Sciences, University of Kuopio, Kuopio, Finland

* Corresponding author. Tel.: +46-46-17-81-53; fax: +46-46-17-81-50
E-mail address: petru.liuba{at}pedi.lu.se

Received 16 September 2002; revised 8 October 2002; accepted 9 October 2002


    Abstract
 Top
 Abstract
 1. Introduction
 2. Methods
 3. Results
 4. Discussion
 References
 
Background Atherosclerosis begins early in life. Infections might contribute to the pathogenesis of atherosclerosis. In this study, we investigated whether acute infections in children could alter the carotid wall morphology and the lipid profile.

Methods Mean carotid intima–media thickness (IMT) was measured by high-resolution ultrasound in 28 hospitalised children (mean age: 5±2 years), who fulfilled the diagnostic criteria of acute infections (body temperature, >38°C; C-reactive protein, >15mg/ml, and clinical), and in 20 age- and gender-matched controls. Antibodies against oxidised low-density lipoprotein (anti-oxLDL antibodies), as well as total and high-density lipoprotein cholesterol (HDL-C) were analysed in all children. The infection group was investigated both during the acute illness and 3 months after clinical recovery (post-infection).

Results During the acute illness, the infection group had elevated anti-oxLDL antibodies and decreased HDL-C, as compared to those obtained at 3 months and in controls . These changes in the infection group were followed, at 3 months, by thickening of carotid intima–media. Those who received antibiotics during their acute illness had less carotid thickening than those who were not treated with antibiotics .

Conclusion Acute infections in children seem to be accompanied by enhanced oxidative modification of LDL and by decrease in HDL-C. These lipid changes may be followed by thickening of carotid artery intima–media. These findings suggest that, in childhood, acute infections could be associated with increased risk of atherosclerosis, and warrant further studies on this topic.

Key Words: Carotid intima–media thickness • Oxidised low-density lipoprotein • High-density lipoprotein • Acute infection


    1. Introduction
 Top
 Abstract
 1. Introduction
 2. Methods
 3. Results
 4. Discussion
 References
 
Atherosclerosis, the major cause of coronary heart disease, begins during early childhood.1 The time-course of atherosclerosis development is not linear. It has been hypothesised that various acute damaging stimuli promote acute vascular injury, which resolves partially only after the cessation of these stimuli.2 Subsequent exposure to additional stimuli would cause further vascular damage. The summed effect of acute vascular damages and incomplete healings could ultimately lead to the development of atherosclerotic plaque.

Although the putative role of infections in the atherosclerosis development is still controversial, negative data being also presented,3,4 accumulative evidence suggests that infections might fit into the aforementioned scenario of atherosclerosis development.5–7 Humans experience, from early childhood, repeated acute infections. Chronic infections commonly undergo, within the sameindividual, repeated relapses accompanied by acute inflammatory and autoimmune reactions. These processes appear to be key-factors in the pathogenesis of atherosclerosis.8 Of note, organisms capable of generating life-long infections with repeated reactivation, such as Chlamydia pneumoniae, Helicobacter pylori, herpes viruses, hepatitis, have been most consistently associated with atherosclerosis development.9–11

Supporting this hypothesis, previous post-mortem studies have shown significant intimal thickenings of coronary arteries in children with signs of infection at their death.12 More recently, studies on young experimental animals have shown intimal thickenings in relation to certain types of acute infections, and provided clues for a possible progression of these changes toward an atherosclerotic lesion.13,14

As yet, there are no in vivo clinical studies questioning possible damaging effects of acute infections on the arterial wall. In the present study, we investigated whether clinically manifest acute infections in children could pose such effects, and we used carotid intima–media thickness (IMT) as a marker of arterial damage. IMT of carotid arteries has been previously validated as a reliable surrogate for tracking early atherosclerotic changes owing to various risk factors for atherosclerosis.15 The method, employing high-resolution ultrasound, is non-invasive and highly reproducible. We also investigated whether acute infections could enhance the oxidative modification of low-density lipoprotein (LDL) by measuring the levels of antibodies against oxidised low-density lipoprotein (anti-oxLDL antibodies). Oxidatively modified LDL has important atherogenic properties, and has been epidemiologically associated with early atherosclerosis.16 Total and high-density lipoprotein cholesterol (HDL-C) were also measured.


    2. Methods
 Top
 Abstract
 1. Introduction
 2. Methods
 3. Results
 4. Discussion
 References
 
2.1. Study material
Twenty-eight children (mean age: 5±2 years), admitted to our hospital with clinically manifest acute infections, such as acute respiratory infections, urinary tract infections, gastroenteritis or other types of infections, were enrolled. Antibiotic treatment (cephalosporins or penicillin) was given to 17 children, depending on their clinical status and C-reactive protein levels. In addition, 20 healthy age and gender-matched controls were selected. Exclusion criteria were coronary heart disease, diabetes, hypertension, smoking and hypercholesterolemia, also if present among first-degree relatives. Written consent was obtained from all children older than 7 years, or from their guardians in case of those younger than 7 years. The study was approved by the Lund University's Ethics Committee for human research.

In the infection group, carotid ultrasound investigation was performed at two different time-points: during the acute infectious illness (body temperature, >38°C and C-reactive protein, >15mg/ml), before or within the first 24h of initiation of medical treatment, and 3 months after recovery from the infectious illness (post-infection). All controls were investigated once. Blood was taken from both the infection groups, during the acute illness and after recovery, and the control group. The samples were then centrifuged and stored at –70°C. The sera were analysed for anti-oxLDL antibodies, while the plasma samples were used for HDL-C and total cholesterol analyses. Data concerning blood pressure, weight, gender, and other clinical (body temperature, antibiotic treatment, when applicable) and laboratory (C-reactive protein, serum glucose) characteristics were also obtained.

2.2. Carotid ultrasound protocol
A high-resolution ultrasound system equipped with a 15-MHz imaging probe (Acuson Sequoia) was used. During each investigation, ECG was recorded continuously and displayed on the ultrasound system's monitor. The imaging protocol has been described in detail elsewhere.17 Briefly, longitudinal scans in bi-dimensional mode of the 1-cm-distal end of the left common carotid artery were imaged so that the lumen–intima and intima–media interfaces were distinguishable. All images corresponded to the R-wave on ECG. Up to four scans were obtained from each child, and were recorded on a videotape for off-line analysis of IMT. All ultrasound scans were taken by the same sonographer (P.L.). The mean carotid IMT was measured from each scan using a computer-assisted image analyser system, previously developed in collaboration between the Wallenberg Laboratory for Cardiovascular Research and the Chalmers University of Technology, Gothenburg, Sweden.17 Mean IMT obtained from all scans from the same subject were averaged, and the resulted mean IMT was used for statistical analyses. All the computer-assisted analyses of carotid IMT were performed by experienced B-mode image readers (Gerd Östling and Birgitta Frid), who were unaware of the clinical characteristics of the studied groups.

The method, using the same image analyser system, has been previously shown to be highly reproducible.17 In our pilot study on 15 children (two sonographers: P.L. and Gerd Östling), the inter-observer and intra-observer variability were 5.7 and 6.4% , respectively.

2.3. Anti-oxLDL antibodies, HDL-C and total cholesterol
A modified ELISA was used to determine anti-oxLDL antibodies. The technique has been described in detail previously.18 The data are expressed as the ratio of binding to oxLDL to binding to native LDL (oxLDL:native LDL).

All blood samples analysed for HDL-C and total cholesterol were collected in tubes containingethylenediamine tetra-acetic acid. Plasma HDL-C and total cholesterol levels were analysed by enzymatic methods using a Hitachi Modular-P system (Roche/Hitachi 912, Roche Diagnostics). All data are expressed in millimoles per liter.

2.4. Sample size calculations
A sample size of 28 was sufficient in order to detect a difference of interest of 0.05mm (approximately 10% of the baseline IMT) with a power of 86% using a paired t-test with a 0.05 two-sided significance level.

2.5. Statistical analysis
Two-way analysis of variance was used to calculate the statistical differences in IMT, anti-oxLDL antibodies, HDL-C, total cholesterol and their ratio (total choltesterol:HDL-C) in the infection group between the time-points (acute infection and post-infection), and between the infection and the control groups. In the infection group, Student's t-test was used to assess the statistical difference in carotid IMT between the antibiotic-treated and the non-treated sub-groups. Carotid IMT was calculated as a difference between carotid IMT at 3 months and carotid IMT during the acute illness. All data are expressed as means±SEM. Significance levels were set at . All analyses were madewith the statistical software STATVIEW for Windows (version 5.0, SAS Institute Inc.).


    3. Results
 Top
 Abstract
 1. Introduction
 2. Methods
 3. Results
 4. Discussion
 References
 
3.1. Carotid IMT
During the acute illness, the infection group had similar carotid IMT to those obtained in the control group (0.41±0.02 versus 0.43±0.02mm, respectively; ; Fig. 1). Instead, 3 months after clinical recovery, the infection group had significantly greater carotid IMT than during the acute illness (0.48±0.02 versus 0.41±0.02mm, respectively; ), and than the control group (0.48±0.02 versus 0.43±0.02mm, respectively; ; Fig. 1). The thickening of carotid intima–media in the infection group was less in those who were treated with antibiotics during their acute illness than those who did not receive antibiotics (0.055±0.02 versus 0.112±0.015mm, respectively; ; Fig. 2).



View larger version (13K):
[in this window]
[in a new window]
 
Fig. 1 Carotid IMT in the infection group during the acute illness (acute inf) and 3 months after recovery (post-inf), and in control subjects. Data are expressed as means±SEM; , and versus acute illness and controls, respectively.

 


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 2 IMT in the infection group during the acute illness (acute inf) and at 3 months (post-inf) in relation to antibiotic treatment (left panel). Thickening of carotid intima–media in the antibiotic-treated and antibiotic-non-treated subgroups (right panel). Data are expressed as mean±SEM; .

 
3.2. Anti-oxLDL antibodies
The anti-oxLDL antibody data are presented in Fig. 3. During the acute illness, the levels of anti-oxLDL antibodies in the infection group were higher than in the control group (2.27±0.22 versus 1.55±0.17, respectively; ). Although the level of anti-oxLDL antibodies in these children at 3 months was still higher than in controls (1.8±0.13 versus 1.55±0.17, respectively), the difference was not significant .



View larger version (10K):
[in this window]
[in a new window]
 
Fig. 3 Anti-oxLDL antibodies in the infection group during the acute illness (acute inf) and at 3 months (post-inf), and in controls. The antibodies against oxLDL are expressed as the ratio of binding to oxLDL to binding to native LDL. Data are expressed as mean±SEM; .

 
3.3. HDL-C and total cholesterol
The data pertaining to HDL-C, and total cholesterol:HDL-C ratio are illustrated in Fig. 4. The plasma levels of HDL-C were significantly decreased in the infection group during the acute illness (0.68±0.07mmol/l) compared to those at 3 months (1.23±0.11mmol/l, ) and controls (1.35±0.06mmol/l, ). Similar differences were observed with regard to total cholesterol, i.e. 3.2±0.15mmol/l during the acute illness versus 4.18±0.22 and 4.14±0.23mmol/l at 3 months and in controls, respectively, . The ratio between total cholesterol and HDL-C was significantly higher in the infection group during the acute illness (6.1±0.7) than at 3 months (3.6±0.4, ) and than controls (3.1±0.2, ). No significant differences in these variables were observed between the infection group at 3 months and the control group.



View larger version (10K):
[in this window]
[in a new window]
 
Fig. 4 HDL-C (Panel A), and total cholesterol (TC):HDL-C ratio (Panel B) in the infection group during the acute illness (acute inf) and at 3 months (post-inf), and in controls. Data are expressed as mean±SEM; , and .

 
There was no significant difference in body weight, blood pressure or serum glucose levels between the infection group, either during the acute illness or convalescence, and the controls.


    4. Discussion
 Top
 Abstract
 1. Introduction
 2. Methods
 3. Results
 4. Discussion
 References
 
The findings indicate that clinically manifest acute infections in children are accompanied by enhanced oxidative modification of LDL and by decrease in plasma HDL-C. The lipid changes may be followed by thickening of carotid intima–media. Of note, antibiotic treatment during the acute infectious illness was associated with less carotid thickening.

Previous studies have demonstrated that the ultrasound-detected thickness of carotidintima–media correlates well with the anatomical thickness of carotid intima.19 In the presence of conventional risk factors for atherosclerosis, thickening of carotid intima–media may be observed by ultrasound in children.15,20,21 There are well-documented similarities in terms of extent and distribution of intimal thickening between carotid and coronary arteries.22

Seroepidemiological studies on adults have shown that several chronic infections are associated with accelerated atherosclerosis in the carotid arteries.9–11 Chronic infections may be accompanied by damage of endothelial cells, hypercoagulability, altered lipid profile andenhanced auto-immunity, all of which might serve as mechanisms in the pathogenesis of atherosclerosis.23 Although these data provide support to a possible contribution of infection to the development of atherosclerosis, it remains unclear whether these vascular changes follow a linear progression as a result of continuous injury triggered by chronic infections or whether they result from periodic spurts of vascular growth and incomplete healing due to repeated episodes of acute reinfections or reactivation of a chronic infection. The latter alternative is in keeping with the natural course of atherosclerosis development as being suggested by data from autopsy24 and serial angiographic25 studies, and is supported by our finding that acute infections could promote vascular changes.

We and other researchers have earlier demonstrated that repeated administration of infectious organisms could lead to progressive endothelial damage and atherosclerotic-like intimal thickening in experimental animals.26,27 These findings favour the idea that residual vascular inflammatory changes may persist following an acute infectiousepisode, and could be further aggravated by a new infectious stimulus. By extrapolating the data from animal studies in clinical setting, one could speculate that subsequent acute infections might have additive effects on a previously damaged and incompletely healed vascular wall and, thus, the process may further evolve toward a mature atherosclerotic lesion.

One attractive hypothesis that might explain the occurrence of intimal thickening in relation to acute infections involves the participation ofarterial endothelium. Arterial endothelial injury following acute infection has been demonstrated in vivo and in vitro in different animal models.26,28 The infectious components, the systemic inflammatory response, e.g. inflammatory cytokines, C-reactive protein, and changes in lipid and homocysteine metabolisms accompanying infections, might all concur to vascular endothelial damage which, in turn, initiates a cascade of humoral- and cell-mediated intravascular processes that could ultimately lead to thickening of vessel's intima.7,29

While a transitory decrease in HDL-C during acute infections has been previously detected in both pediatric and adult population,30,31 being also documented in our study, the finding of enhanced oxidative modification of LDL in children with acute infection is novel. The oxidatively modified LDL could lead per se to intimal thickening even after a short-time exposure.32 This thickening involves both inflammatory and proliferative intimal changes, illustrating the atherogenic properties of oxidised LDL. Their detrimental effects might be exacerbated by lessening in the protective vascular mechanisms due to decreased HDL-C.19 The oxidative modification of LDL in vivo is possibly part of a complex, but non-specific host response toinfection.33

In the present study, antibiotic treatment during the acute illness was associated with less IMT. Although beneficial effects of antibiotics on intimal thickening and atherosclerosis development in relation to particular types of infections have been observed in experimental studies and in a few clinical trials, other trials have failed to demonstrate this association.34 Besides their antimicrobial properties, the anti-inflammatory and antioxidant properties might also account for the beneficial effects of antibiotics. Alternatively, the less thickening in relation to antibiotic treatment might be rather due to the type of infection, i.e. bacteria versus viruses, since most of the antibiotic-treated children were likely to have more bacterial infections than the ones in non-treated group.

In conclusion, clinically manifest acute infections in children are accompanied by transitory pro-atherogenic lipid changes, and are followed by thickening of carotid intima–media. These findings suggest that acute infections might pose a risk of atherosclerosis in childhood, and are concordant with the epidemiologically suggested concept that infections might contribute to the development of atherosclerotic coronary heart disease. The findings warrant further studies on larger pediatric samples with acute infections, including larger control samples in order to avoid spurious significances, and follow-up studies in order to further elucidate their putative linkage to atherosclerosis. Such studies are imperative since the prevention of atherosclerotic coronary heart disease is best accomplished by combating its risk factors early in life.


    Acknowledgments
 
We are indebted to Ms Gerd Östling and Ms Birgitta Frid, laboratory technicians, for their valuable assistance in computer-assisted analyses of carotid IMT, and to Laura Darcy, registered nurse, for assistance provided throughout the study. We also thank our colleagues and nurses from the Department of Infectious Diseases, Division of Paediatrics, Lund, for their cooperation in recruiting the children with infections.


    References
 Top
 Abstract
 1. Introduction
 2. Methods
 3. Results
 4. Discussion
 References
 

  1. Stary HC. Macrophages, macrophages foam cells, and eccentric intimal thickening in the coronary arteries of young children. Atherosclerosis. 1987;64:91–108.[Medline]
  2. Ross R, Glomset JA. The pathogenesis of atherosclerosis. N Engl J Med. 1976;295:369–377.[Medline]
  3. Ridker P, Hennekens C, Buring J et al. Baseline IgG antibody titers to Chlamydia pneumoniae, Helicobacter pylori, herpes simplex virus, and cytomegalovirus and the risk of cardiovascular disease in women. Ann Intern Med. 1999;131:573–577.[Abstract/Free Full Text]
  4. Nieto F, Folsom A, Sorlie P et al. Chlamydia pneumoniae infection and incident coronary heart disease: the Atherosclerosis Risk in Communities Study. Am J Epidemiol. 1999;150:149–156.[Abstract]
  5. Leinonen M, Saikku P. Infections and atherosclerosis. Scand Cardiovasc J. 2000;34:12–20.[CrossRef][Medline]
  6. Nieto FJ. Infections and atherosclerosis: new clues from an old hypothesis? Am J Epidemiol. 1998;148:937–948.[Medline]
  7. O'Connor S, Taylor C, Campbell L et al. Potential infectious etiologies of atherosclerosis: a multifactorial perspective. Emerg Infect Dis. 2001;7:780–788.[Medline]
  8. Libby P, Ridker P, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135–1143.[Abstract/Free Full Text]
  9. Mayr M, Kiechl S, Willeit J et al. Infections, immunity and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis. Circulation. 2000;102:833–839.[Abstract/Free Full Text]
  10. Ishizaka N, Ishizaka Y, Takahashi E et al. Increased prevalence of carotid atherosclerosis in hepatitis B virus carriers. Circulation. 2002;195:1028–1030.[CrossRef]
  11. Chiu B, Viira E, Tuccker V et al. Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery. Circulation. 1997;96:2144–2148.[Abstract/Free Full Text]
  12. Pesonen E, Paakkari I, Rapola J. Infection-associatedintimal thickening in the coronary arteries of children. Atherosclerosis. 1999;142:425–429.[CrossRef][Medline]
  13. Koskinen P, Lemstrom K, Bruggeman C et al. Acute cytomegalovirus infection induces a subendothelial inflammation (endothelialitis) in the allograft vascular wall. A possible linkage with enhanced allograft arteriosclerosis. Am J Pathol. 1994;144:41–50.[Abstract]
  14. Laitinen K, Laurila A, Pyhala L et al. Chlamydia pneumoniae infection induces inflammatory changes in the aortas of rabbits. Infect Immun. 1997;65:4832–4835.[Abstract]
  15. Tonstad S, Joakimsen O, Stensland-Bugge E et al. Risk factors related to carotid intima–media thickness and plaque in children with familial hypercholesterolemia and control subjects. Arterioscler Thromb Vasc Biol. 1996;16:984–991.[Abstract/Free Full Text]
  16. Ylä-Herttuala S. Is oxidized low-density lipoprotein present in vivo? Curr Opin Lipidol. 1998;9:337–344.[CrossRef][Medline]
  17. Persson J, Stavenow L, Wikstrand J et al. Noninvasivequantification of atherosclerosis. Reproducibility of ultrasonographic measurement of arterial wall thickness and plaque size. Arterioscler Thromb. 1992;12:261–266.[Abstract]
  18. Erkkilä A, Närvanen O, Lehto S et al. Autoantibodies against oxidized low-density lipoprotein and cardiolipin in patients with coronary heart disease. Arterioscler Thromb Vasc Biol. 2000;20:204–209.[Abstract/Free Full Text]
  19. Pignoli P, Tremoli E, Poli A et al. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation. 1986;74:1399–1406.[Abstract]
  20. Virkola K, Pesonen E, kerblom H et al. Cholesterol and carotid artery wall in children and adolescents with familial hypercholesterolaemia: a controlled study by ultrasound. Acta Paediatr. 1997;86:1203–1207.[Medline]
  21. Jarvisalo M, Putto-Laurila A, Jartti L et al. Carotid artery intima–media thickness in children with type 1 diabetes. Diabetes. 2002;51:493–498.[Abstract/Free Full Text]
  22. Hulthe J, Wikstrand J, Emanuelsson H et al. Atherosclerotic changes in the carotid artery bulb as measured by B-mode ultrasound correlate with the extent of coronary atherosclerosis. Stroke. 1997;28:1189–1194.[Abstract/Free Full Text]
  23. Libby P, Egan D, Skarlatos S. Roles of infectious agents in atherosclerosis and restenosis. Circulation. 1997;96:4095–4103.[Free Full Text]
  24. Rapola J, Pesonen E. Coronary artery changes in newborn babies. A histological and electron microscopical study. Acta Pathol Microbiol Scand. 1977;85:286–296.
  25. Bruschke A, Kramer J Jr, Bal E et al. The dynamics of progression of coronary atherosclerosis studied in 168 medically treated patients who underwent coronary arteriography three times. Am Heart J. 1989;117:296–305.[Medline]
  26. Liuba P, Karnani P, Pesonen E et al. Endothelial dysfunction after repeated Chlamydia pneumoniae infection in apolipoprotein E-knockout mice. Circulation. 2000;102:1039–1044.[Abstract/Free Full Text]
  27. Moazed T, Campbell L, Rosenfeld M et al. Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. J Infect Dis. 1999;180:238–241.[CrossRef][Medline]
  28. Liuba P, Pesonen E, Paakkari I et al. Chlamydial infection—a trigger factor for atherosclerosis and acute coronary events. Atherosclerosis. 2001;2(2):78–79.
  29. Bonnefont-Rousselot D, Thérond P, Beaudeux JL et al. High density lipoproteins and the oxidative modification of atherosclerosis. Clin Chem Lab Med. 1999;37:934–948.
  30. Pesonen E, Rapola J, Viikari J. Altered serum lipid profile after systemic infection in children: risk factor for CHD? Eur Heart J. 1993;14(Suppl K):7–11.
  31. Gidding S, Stone N, Bookstein L et al. Month-to-month variability of lipids, lipoproteins, and apolipoproteins and the impact of acute infection in adolescents. J Pediatr. 1998;133:242–246.[Medline]
  32. Matthys K, Van Hove C, Kockx M et al. Local application of LDL promotes intimal thickening in the collared carotid artery of the rabbit. Arterioscler Thromb Vasc Biol. 1997;17:2423–2429.[Abstract/Free Full Text]
  33. Hajjar D. Oxidized lipoproteins and infectious agents. Are they in collusion to accelerate atherogenesis? Arterioscler Thromb Vasc Biol. 2000;20:1421–1422.[Free Full Text]
  34. Muhlestein JB. Infectious agents, antibiotics, and coronary artery disease. Curr Interv Cardiol Rep. 2000;2:342–348.[Medline]